Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Squamous Cell Carcinoma of Oral Cavity”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Testing effectiveness (Phase 2)UnknownNCT06130007
What this trial is testing

A Prospective, Single-arm Phase II Clinical Trial of Tislelizumab Combined With Platinum Doublet Neoadjuvant Therapy to Improve Mandibular Preservation in Resectable Locally Advanced Oral Squamous Cell Carcinoma.

Who this might be right for
Oral Squamous Cell Carcinoma
Xuekui Liu 48
Large-scale testing (Phase 3)Looking for participantsNCT05125055
What this trial is testing

Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC

Who this might be right for
Oral Squamous Cell CarcinomaNeoadjvant TherapyAnti-PD-1+1 more
Shanghai Jiao Tong University School of Medicine 80
Testing effectiveness (Phase 2)Study completedNCT00276523
What this trial is testing

PEG-interferon Alfa-2b in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer That Can Be Removed By Surgery

Who this might be right for
Head and Neck Cancer
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07400094
What this trial is testing

Neoadjuvant Chemoimmunotherapy (Camrelizumab + Paclitaxel + Carboplatin) for Resectable HNSCC

Who this might be right for
Squamous Cell Carcinoma of Head and NeckLaryngeal NeoplasmsOral Cavity Neoplasm
National Medical Research Radiological Centre of the Ministry of Health of Russia 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03174275
What this trial is testing

Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma

Who this might be right for
Carcinoma, Squamous CellOral CancerOropharynx Cancer+3 more
UNC Lineberger Comprehensive Cancer Center 39
Testing effectiveness (Phase 2)Ended earlyNCT02331875
What this trial is testing

Efficacy Study of Pre-operative IPH2201 in Patients With Squamous Cell Carcinoma of the Oral Cavity

Who this might be right for
Squamous Cell Carcinoma of the Oral Cavity
Innate Pharma 3
Large-scale testing (Phase 3)Study completedNCT00003576
What this trial is testing

Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery

Who this might be right for
Head and Neck Cancer
National Cancer Centre, Singapore 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07079410
What this trial is testing

Neoadjuvant and Adjuvant Sintilimab Plus Cetuximab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Oral Squamous Cell Carcinoma (OSCC)Oropharyngeal Squamous Cell CarcinomaResectable Oral and Oropharyngeal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06728618
What this trial is testing

Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Oral Squamous Cell Carcinoma (OSCC)Oropharyngeal Squamous Cell Carcinoma (SCC)Resectable Oral and Oropharyngeal Squamous Cell Carcinoma+1 more
Shanghai Zhongshan Hospital
Testing effectiveness (Phase 2)Study completedNCT01914900
What this trial is testing

Preoperative TPF Chemotherapy in Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer

Who this might be right for
Locally Advanced Resectable Oral Cavity Squamous Cell Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 14
Early research (Phase 1)Ended earlyNCT04588038
What this trial is testing

NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing Surgery

Who this might be right for
Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+3 more
Hyunseok Kang, MD 4
Large-scale testing (Phase 3)Study completedNCT01542931
What this trial is testing

TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma

Who this might be right for
Stage III Oral Cavity Squamous Cell CarcinomaStage IVA Oral Cavity Squamous Cell Carcinoma
Shanghai Jiao Tong University School of Medicine 256
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07484139
What this trial is testing

H&N NEO-COMBAT XL: Neoadjuvant XL-092 (Zanzalintinib) and Pembrolizumab (Keytruda) in Surgically Resectable, HPV Negative Oral Cavity Squamous Cell Carcinoma (OCSCC)

Who this might be right for
Oral Cavity Squamous Cell CarcinomaHead and Neck Cancer
UNC Lineberger Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT05681039
What this trial is testing

Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).

Who this might be right for
Squamous Cell CarcinomaOral Cavity Squamous Cell Carcinoma
M.D. Anderson Cancer Center 29
Not applicableLooking for participantsNCT07686575
What this trial is testing

Objective Response Rate of Ivonescimab With Chemotherapy in Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
HNSCCOSCCOPSCC+1 more
Zhujiang Hospital 20
Large-scale testing (Phase 3)Study completedNCT00002670
What this trial is testing

Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery

Who this might be right for
Head and Neck Cancer
Radiation Therapy Oncology Group 459
Testing effectiveness (Phase 2)Ended earlyNCT00566540
What this trial is testing

Ph 2 Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell Cancer

Who this might be right for
Head and Neck Cancer
Ohio State University Comprehensive Cancer Center 11
Not applicableStudy completedNCT06143761
What this trial is testing

Response to Neoadjuvant Chemoimmunotherapy in Resectable Locally Advanced Oral Cancer

Who this might be right for
Oral Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 206
Early research (Phase 1)WithdrawnNCT03575234
What this trial is testing

Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal Cancer

Who this might be right for
Human Papillomavirus Positive Oropharyngeal Squamous Cell CarcinomaStage II Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7+2 more
Emory University
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07778368
What this trial is testing

A Multicenter, Prospective, Phase II Study of TROP-2 ADC in Combination With Toripalimab for Resectable Locally Advanced Oral Squamous Cell Carcinoma

Who this might be right for
Oral Squamous Cell Carcinoma (OSCC)
Shanghai East Hospital 20
Next Page
28